Quantitative real-time PCR for cancer detection: The lymphoma case

Expert Review of Molecular Diagnostics

Volumn 5, Issue 2, 2005, Pages 221-230

  Ståhlberg, Anders ^a,b   Zoric, Neven ^a   Åman, Pierre ^c   Kubista, Mikael ^a,b  

^a TATAA Biocenter AB   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer diagnostics; Gene expression analysis; Lymphoma; Normalization; Real time PCR

Indexed keywords

ACCURACY; ASPIRATION BIOPSY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; LYMPHOMA; MOLECULAR PROBE; QUALITY CONTROL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY ANALYSIS;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LYMPHOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 15444365256     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.5.2.221     Document Type: Review

References (85)

1. Bustin SA. Absolute quantification of mRNA using teal-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25(2), 169-193 (2000). •• First extensive review of quantitative real-time PCR.
2. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J. Mol. Endocrinol. 29(1), 23-29 (2002).
3. Dyrskjot L. Classification of bladder cancer by microarray expression profiling: towards a general clinical use of micorarrays in cancer diagnostics. Expert. Rev. Mol. Diagn. 3(5), 635-647 (2003).
4. Ginzinger DG. Gene quantification using real-time quantitative PCR; an emerging technology hits the mainstream. Exp. Hematol. 30(6), 503-512 (2002).
5. Bernard PS, Wittwer CT. Real-time PCR technology for cancer diagnostics. Clin. Chem. 48(8), 1178-1185 (2002).
6. Klein D. Quantification using real-time PCR technology, application and limitations. Trends Mol. Med. 8(6), 257-260 (2002).
7. Walker NJ. Tech. Sight. A technique whose time has come. Science 296(5567), 557-559 (2002).
8. Liss B, Roeper J. Correlating function and gene expression of individual basal ganglia neurons. Trends Neurosci. 27(8), 475-481 (2004). • Discusses the potential of quantitative single-cell analyses.
9. Pfaffl MW. A new mathematical model for relative quantification in real-time PCR RT-PCR. Nucleic Acuis Res. 29(9), E45 (2001). • Technical study that describes the mathematical model for relative quantification.
10. Wilhelm J, Pingoud A, Real-time polymerase chain reaction. Chembiochem 4(11), 1120-1128(2003).
11. Kubista M, Zoric N. Real-time PCR Platforms. In: Encyclopedia of Medical Genomics and Proteomics. Marcel Dekker Inc., NY, USA (2005) (In Press).
12. Ståhlberg A, Håkansson J, Xian X, Semb H, Kubista M. Properties of the reverse transcription reaction in mRNA quantification. Clin. Chem. 50(3), 509-515 (2004).
13. Ståhlberg A, Kubista M, Pfaffl M. Comparison of reverse transcriptases in gene expression analysis. Clin. Chem. 50(9), 1678-1681 (2004).
14. Peters IR, Helps CR, Day MJ. Real-time RT-PCR: considerations for efficient and sensitive assay design. J. Immunol. Methods 286(1-2), 203-217 (2004).
15. Wang X, Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res. 31(24), E154 (2003).
16. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. BioTechniques 22(1), 130-138 (1997).
17. Zipper H, Brunner H, Bernhagen J, Viczthum F. Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications. Nucleic Acids Res. 32(12), E103 (2004).
18. Bengtsson M, Karlsson JH, Westman G, Kubista M. A new minor groove binding asymmetric cyanine reporter dye for real-time PCR. Nucleic Acids Res. 31(8), E45 (2003).
19. Ririe KM, Rasmussen RP, Wittwer CT. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal. Biochem. 245(2), 154-160 (1997).
20. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl Acad. Sci. USA 88(16), 7276-7280 (1991).
21. Tyagi S, Kramer FR. Molecular beacons: probes that fluorescence upon hybridization. Nature Biotechnol. 14(3), 303-308 (1996).
22. Tyagi S, Bratu DP, Kramer FR. Multicolor molecular beacons for allele discrimination. Nature Biotechnol. 16(1), 49-53 (1998).
23. Caplin BE, Rasmussen RP, Bernard PS, Wittwer CT. LightCycler™ hybridization probes - the most direct way to monitor PCR amplification and mutation detection. Biochemica 1, 5-8 (1999).
24. Braasch DA, Corey DR. Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem. Biol. 8(1), 1-7 (2001).
25. Lakowicz JR, DNA technology. In: Principles of Fluorescence Spectroscopy, second edition. Kluwer Academic/Plenum Publishers, NY, USA, 595-617 (1999).
26. Svanvik N, Ståhlberg A, Sehlstedt U, Sjöback R, Kubista M. Detection of PCR products in real time using light-up probes. Anal. Biochem. 287(1), 179-182 (2000).
27. Kutyavin IV, Afonina IA, Mills A et al. 3′-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res. 28(2), 655-661 (2000).
28. Whitcombe D, Theaker J, Guy SP, Brown T, Little S. Detection of PCR products using self-probing amplicons and fluorescence. Nature Biotechnol. 17(8), 804-807 (1999).
29. Nazarenko I, Lowe B, Darfler M, Ikonomi P, Schuster D, Rashtchian A. Multiplex quantitative PCR using self-quenched primers labelled with a single fluorophore. Nucleic Acids Res. 30(9), E37 (2002).
30. Uehara H, Nardone G, Nazarenko I, Hohman RJ. Detection of telomerase activity utilizing energy transfer primers: comparison with gel- and ELISA-based detection. Biotechniques 26(3), 552-558 (1999).
31. BD QZyme™ assays for quantitative PCR. Clontechniques 18(4), 2-3 (2003).
32. Tichopad A, Dilger M, Schwarz G, Pfaffl M. Standardized determination of real-time PCR efficiency from a single reaction set-up. Nucleic Acids Res. 31(20), E122 (2003).
33. Bar T, Ståhlberg A, Muszta A, Kubista M. Kinetic outlier detection (KOD) in real-time PCR. Nucleic Acids Res. 31(17), E105 (2003). • Describes how individual amplification response curves may be used to identify PCR-inhibited samples.
34. Mhlanga MM, Malmberg L. Using molecular beacons to detect single-nucleotide polymorphisms with teal-time PCR. Methods 25(4), 463-471 (2001).
35. Bonnet G, Tyagi S, Libchaber A, Kramer FR. Thermodynamic basis of the enhanced specificity of structured DNA probes. Proc. Natl Acad. Sci. USA 96(5), 6171-6176 (1999).
36. Kubista M. Nucleic acid-based technologies: application amplified. Pharmacogenomics 5(6), 767-773 (2004).
37. Ståhlberg A, Åman P, Ridell B, Mostad P, Kubista M. Quantitative real-time PCR method for detection of B-lymphocyte monoclonality by comparison of κ and λ immunoglobulin light chain expression. Clin. Chem. 49(1), 51-59 (2003). • Describes how immunoglobulin light chains κ and λ can be used as a test for monoclonality in B-cell lymphomas.
38. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30(9), E36 (2002).
39. Szabo A, Perou CM, Karaca M, Perreard L, Quackenbush JF, Bernard PS. Statistical modeling for selecting housekeeper genes. Genome Biol. 5(8), R59 (2004).
40. Vandesompele J, de Preter K, Pattyn F et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3(7), research0034 (2002). •• Describes GeNorm, a method to identify constantly expressed reference genes.
41. Akilesh S, Shaffer DJ, Roopenian D. Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. Genome Res. 13(7), 1719-1727 (2003).
42. Husson H, Carideo EG, Neuberg D et al. Gene expression profiling of follicular lymphoma and normal germinal center B-cells using cDNA arrays. Blood 99(1), 282-289 (2002).
43. Shin MS, Fredrickson TN, Hartley JW, Suzuki T, Agaki K, Morse HC III. High-throughput tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. Cancer Res. 64(13), 4419-4427 (2004).
44. Tsukasaki K, Tanosaki S, deVos S et al. Identifying progression- associated genes in adult T-cell leukaemia/lymphoma by using oligonucleotide microarrays. Int. J. Cancer 109(6), 875-881 (2004).
45. Coiffier B. Diffuse large cell lymphoma. Curr. Opin. Oncol. 13(5), 325-334 (2001).
46. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769), 503-511 (2000).
47. Rosenwald A, Wright G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N. Engl. J. Med. 346(25), 1937-1947 (2002).
48. Shipp MA, Ross KN, Tamayo P. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised learning. Nature Med. 8(1), 68-74 (2002).
49. Robetorye RS, Bohling SD, Morgan JW, Fillmore GC, Lim MS, Elenitoba-Johson KSJ. Microarray ananlysis of B-cell lymphoma cell lines with the t(14;18). J. Mol. Diagn. 4(3), 123-136 (2002).
50. Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B-cell lymphoma. Proc. Natl Acad. Sci. USA 100(17), 9991-9996 (2003).
51. Mah N, Thelin A, Lu T et al. A comparison ofoligonucleotide and cDNA-based microarray systems. Physiol. Genomics 16(3), 361-370 (2004).
52. Lossos IS, Czerwinski DK, Alizadeh AA et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N. Engl. J. Med. 350(18), 1828-1837 (2004). •• Validated six genes that may predict survival in diffuse large B-cell lymphoma using real-time PCR.
53. Jones CD, Darnell KH, Warnke RA, Zehnder JL. Cyclin D1/Cydin D3 ratio by real-time PCR improves specificity for the diagnosis of mantle cell lymphoma. J. Mol. Diagn. 6(2), 84-89 (2004).
54. Howe JG, Crouch J, Cooper D, Smith BR. Real-time quantitative reverse transcription-PCR for cydin D1 mRNA in blood, marrow, and tissue specimens for diagnosis of mantle cell lymphoma. Clin. Chem. 50(1), 80-87 (2004).
55. Katayama Y, Sakai A, Okikawa Y et al. Cyclin D1 over expression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells. Int. J. Oncol. 25(3), 79-95 (2004).
56. Bennaceur-Griscelli A, Bosq J, Koscielny S et al. High level of glutathione-S-transferase pi expression in mantle cell lymphomas. Clin. Cancer Res. 10(9), 3029-3034 (2004).
57. Malec M, Söderqvist M, Sirsjö A et al. Real-time polymerase chain reaction determination of cytokine mRNA expression profiles in Hodgkin's lymphoma. Heamatologica 89(6), 679-685 (2004).
58. Lossos IS, Czerwinski DK, Wechser MA, Levy R. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. Leukemia 17(4), 789-795 (2003).
59. Beillard E, Pallisgaard N, van der Velden VH et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using real-time quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 17(12), 2474-2486 (2003).
60. Stentoft J, Pallisgaard N, Kjeldsen E, Holm MS, Nielsen JL, Hokland P. Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukaemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction. Eur. J. Haematol. 67(5-6), 302-308 (2001).
61. Ment K, Muller MC, Kreil S et al. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of Interferon alpha. Leukemia 16(9), 1579-1583 (2002).
62. Rambaldi A, Lazzari M, Manzoni C et al. Monitoring of minimal residual disease after CHOP and rituximab in previosly untreated patients with follicular lymphoma. Blood 99(3), 856-862 (2002).
63. Yao R, Rich SA, Schneider E. Validation of sixteen leukemia and lymphoma cell lines as controls for molecular gene rearrangement assays. Clin. Chem. 48(8), 1344-1351 (2002).
64. Arber DA. Molecular diagnostics approach to non-Hodgkin's lymphoma. J. Mol. Diagn. 2(4), 178-190 (2000).
65. Vega F, Medeiros J. Chromosomal translocations involved in non-Hodgkin lymphomas. Arch. Pathol. Lab. Med. 127(9), 1148-1160(2003).
66. van del Veldn VHJ, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJM. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR; principles, approaches, and laboratory aspects. Leukemia 17(6), 1013-1034 (2003).
67. Yashima A, Maesawa C, Uchiyama M et al. Quantitative assessment of contaminating tumor cells in autologous peripheral blood stem cells of B-cell non-Hodgkin lymphomas using immunoglobulin heavy chain gene allele-specific oligonucleotide real-time quantitative-polymerase chain reaction. Leukemia Res. 27(10), 925-934 (2003).
68. Donovan JW, Ladetto M, Zou G et al. Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia. Blood 95(8), 2651-2658 (2000).
69. Uchiyama M, Maesawa C, Yashima A et al. Development of consensus fluorogenically labelled probes of the immunoglobulin heavy-chain gene for detecting minimal residual disease in B-cell non-Hodgkin lymphoma. Conor Sci. 94(10), 877-885 (2003).
70. Lee WI, Cabanillas F, Lee MS. Quantitative assessment of disease involvement by follicular lymphoma using real-time polymerase chain reaction measurement of t(14;18)-carrying cells. Int. J. Hematol. 79(2), 152-156(2004).
71. Liss B. Improved quantitative real-time RT-PCR for expression profiling of individual cells. Nucleic Acids Res, 30(17), E89 (2002).
72. Liss B, Franz O, Sewing S, Bruns R, Neuhoff H, Roeper J. Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KCip3.1 transcription. EMBO J. 20(20), 5715-5724 (2001).
73. Chiang M, Melton DA. Single-cell transcript analysis pf pancreas development. Dev. Cell 4(3), 383-393 (2003).
74. Nun SL, Vambrie S, Steinlein P et al. Independent regulation of the two Pax5 alleles during B-cell development. Nature Genet. 21(4), 390-395 (1999).
75. Velculscu VE, Madden SL, Zhang L et al. Analyis of human transcriptomes. Nature Genet. 23(4), 387-388 (1999).
76. Todd R, Margolin DH. Challenges of single-cell diagnostics: analysis of gene expression. Trends Mol. Med. 8(6), 254-257 (2002).
77. Peccoud J, Jacob C. Theoretical uncertainty of measurements using quantitative polymerase chain reaction. Biophys. J. 71(1), 101-108(1996).
78. Al-Soud WA, Jonsson LJ, Rådström P. Identification and characterization of immunoglobulin G in blood as a major inhibitor of diagnostic PCR. J. Clin. Microbiol. 38 (1), 345-350 (2000).
79. Ramakers C, Ruijter JM, Deprez RH, Moorman AF. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 339(1), 62-66 (2003).
80. Liu W, Saint DA. Validation of a quantitative method for real time PCR kinetics. Biochem. Biophys. Res. Commun. 294(2), 347-353 (2002).
81. Burggraf S, Olgemöller B. Simple technique for internal control of real-time amplification assays. Clin. Chem. 50(5), 819-825 (2004).
82. Cronin M, Ghosh K, Sistare F, Quackenbush J, Vilker V, O'Connell C. Universal RNA reference materials for gene expression. Clin. Chem. 50(8), 1464-1471 (2004). • Meeting report that discusses the design and use of universal reference samples.
83. Specht K, Richter T, Muller U, Walch A, Werner M, Hoefler H. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am. J. Pathol. 158(2), 419-429 (2001).
84. Godfrey TE, Kim SH, Chavira M et al. Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5 nuclease quantitative reverse transcription-polymerase chain reaction. J. Mol. Diagn. 2(2), 84-91 (2000).
85. Rutledge RG, Cote C. Mathematics of quantitative kinetic PCR and the application of standard curves. Nucleic Acids Res. 31(16), E93 (2003).